Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 204 participants.

Also called NCT06472921

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 204 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06472921
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06472921. Randomized; single masking; primary purpose treatment. Start 2024-07-29 (actual); primary completion 2025-11-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.
Condition
Acute Ischemic Stroke
Intervention (Behavioral)
Butylphthalide treatment initiation time
Lead sponsor
Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct06472921
Content hash
9362f53279e063369f52065a2755ebd45fd6ba480258b18eb330ec7d9407d263